Can we predict who will benefit most from atrial fibrillation ablation?

NCT ID NCT06381245

Completed Knowledge-focused Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 340 people with atrial fibrillation who are having their first ablation procedure. Researchers will track heart rhythm using remote monitoring, along with imaging and blood tests, to find which factors—like patient health, heart structure, or electrical signals—best predict whether the ablation works. The goal is to better understand why some people stay free of arrhythmia while others experience a return of the condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors personalize treatment plans and improve long-term outcomes for people with atrial fibrillation.
What could go wrong: This is an observational registry, not a treatment trial. It may identify patterns but won't prove what causes success or failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIA ATRIAL FIBRILLATION

Contacts and locations

Locations

Medical University of Warsaw

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.